Recurrent Treatment in Ovarian Cancer Patients: What Are the Best Regimens and the Order They Should Be Given?

Glajzer, Joanna; Grabowski, Jacek P; Sehouli, Jalid; Pfisterer, Jacobus

Glajzer, Joanna; Grabowski, Jacek P; Sehouli, Jalid; Pfisterer, Jacobus.

Afiliación

Glajzer J; Department of Gynecology and Center of Oncological Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany. joanna.glajzer@charite.de.
Grabowski JP; Department of Gynecology and Center of Oncological Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Sehouli J; Department of Gynecology and Center of Oncological Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Pfisterer J; Gynecologic Oncology Center, Kiel, Germany.

Curr Treat Options Oncol ; 21(6): 49, 2020 04 30.

Article en En | MEDLINE | ID: mdl-32350695

Asunto(s)

Neoplasias Ováricas/terapia; Algoritmos; Toma de Decisiones Clínicas; Terapia Combinada/métodos; Manejo de la Enfermedad; Femenino; Humanos; Neoplasias Ováricas/patología; Recurrencia; Retratamiento; Resultado del Tratamiento

Palabras clave

Chemotherapy ovarian cancer; PARP inhibitors; Recurrent ovarian cancer; Surgery ovarian cancer recurrence; Treatment ovarian cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Curr Treat Options Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google